Media stories about Teladoc (NYSE:TDOC) have been trending somewhat positive on Saturday, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Teladoc earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news headlines about the health services provider an impact score of 45.6725415257577 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the news headlines that may have effected Accern Sentiment’s analysis:
- Teladoc, Inc. (TDOC) Receives Consensus Rating of “Buy” from Analysts (americanbankingnews.com)
- Teladoc Earns Esteemed HITRUST Security Certification (finance.yahoo.com)
- Teladoc, Inc. – Value Analysis (NYSE:TDOC) : August 12, 2017 (finance.yahoo.com)
- Eagle Asset Management Inc Modifies Its Investment in Teladoc, Inc. (TDOC) – First News 24 (firstnewspaper24.com)
- Eagle Asset Management Inc Increases Its Holdings in Teladoc, Inc. (TDOC) Stock Last Quarter – First News 24 (firstnewspaper24.com)
Shares of Teladoc (NYSE:TDOC) traded down 1.14% during trading on Friday, hitting $30.35. 682,680 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of $33.88 and a 200-day moving average price of $27.52. The stock’s market cap is $1.72 billion. Teladoc has a one year low of $14.00 and a one year high of $36.90.
Teladoc (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.02. Teladoc had a negative net margin of 47.75% and a negative return on equity of 19.88%. The business had revenue of $44.60 million during the quarter, compared to the consensus estimate of $44.39 million. During the same quarter in the prior year, the firm posted ($0.38) EPS. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. Equities research analysts expect that Teladoc will post ($1.47) EPS for the current fiscal year.
A number of equities analysts recently issued reports on TDOC shares. Zacks Investment Research downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a research note on Tuesday, May 2nd. TheStreet downgraded shares of Teladoc from a “c-” rating to a “d” rating in a research note on Monday, July 3rd. Craig Hallum downgraded shares of Teladoc from a “buy” rating to a “hold” rating and increased their price target for the stock from $28.00 to $32.00 in a research note on Friday, May 12th. Piper Jaffray Companies reissued an “overweight” rating and issued a $32.00 price target on shares of Teladoc in a research note on Wednesday, June 21st. Finally, KeyCorp started coverage on shares of Teladoc in a research note on Wednesday, May 17th. They issued an “overweight” rating and a $37.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $35.55.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Teladoc (TDOC) Stock Price” was first posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/2809289/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-teladoc-tdoc-stock-price.html.
In related news, CEO Jason N. Gorevic sold 14,400 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $29.57, for a total transaction of $425,808.00. Following the completion of the transaction, the chief executive officer now owns 822,961 shares in the company, valued at approximately $24,334,956.77. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Mark Hirschhorn sold 100,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $27.70, for a total transaction of $2,770,000.00. Following the transaction, the vice president now owns 80,887 shares of the company’s stock, valued at approximately $2,240,569.90. The disclosure for this sale can be found here. In the last 90 days, insiders sold 207,186 shares of company stock valued at $6,122,950. Company insiders own 5.94% of the company’s stock.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.